Data in Table 6 suggested that some proteins such as CRP, TF, APOC3, and VWF might inhibit MG development, while others (e.g., APOA2 and ITIH2) have potential promotional effects on MG progression. The gene discussed is TF; the disease is myasthenia gravis.